Semax (10mg Vial)

Semax

•Synthetic heptapeptide analog of ACTH(4–10).

•Developed in Russia and mainly studied for:

•cognitive effects

•neuroprotection

•Most published clinical literature uses intranasal administration, but some research discussions reference subcutaneous (SC) routes as a once-daily alternative.

Educational research dosing concepts (preclinical / non-human discussions)

•Common referenced daily range: 300–800 mcg

•Typically introduced at lower amounts first.

•Gradual titration is often described in research contexts.

⸻

Reconstitution (educational reference)

•Vial content: 10 mg Semax

•Add: 2.0 mL bacteriostatic water (BAC water)

General lab handling concepts:

•Use sterile technique.

•Slowly add diluent down vial wall.

•Allow peptide to dissolve fully (≈20 minutes mentioned).

•Avoid aggressive shaking.

Concentration after reconstitution

Let’s calculate:

Step 1 — Convert mg to mcg

•10 mg = 10,000 mcg

Step 2 — Divide by total volume

10{,}000 \text{ mcg} \div 2.0 \text{ mL} = 5{,}000 \text{ mcg/mL}

Final concentration:

5,000 mcg per mL

U-100 insulin syringe reference

Key fact:

•U-100 insulin syringe = 100 units = 1.0 mL

So:

•1 unit = 0.01 mL

•10 units = 0.1 mL

•50 units = 0.5 mL

For example:

500 mcg = 0.1 mL

On a U-100 insulin syringe:

0.1 mL = 10 units (the “10” mark)